Search for Clinical Trial Results
Amyloidosis - 257 Studies Found
Status | Study |
Active, not recruiting |
Study Name: Safety And Efficacy Evaluation Of Fx-1006A In Subjects With Transthyretin Amyloidosis Condition: ATTR-PN Date: 2009-06-17 Interventions: Drug: Tafamidis 20 mg oral Fx-1006A daily |
Not yet recruiting |
Study Name: Radioisotope Scintigraphy to Establish Incidence of Cardiac Amyloidosis Among Patients With Otherwise Unexplained Cardiac Disease Condition: Cardiac TTR Amyloidosis Date: 2017-03-28 Interventions: Diagnostic Test: Tc99m-labeled pyrophosphate scan Intravenous injection of Tc99m-labeled pyrophosphate w |
Withdrawn |
Study Name: The Effect of an Antisense Oligonucleotide to Lower Transthyretin (TTR) Levels on the Progression of -Wild-type TTR Involving the Heart Condition: Amyloidosis Date: 2015-11-19 Interventions: Drug: Isis 420915/GSK 299872 Open label study in comparison to historic control. |
Active, not recruiting |
Study Name: Tolerability and Efficacy of a Combination of Doxycycline and TUDCA in Patients With Transthyretin Amyloid Cardiomyopathy Condition:
Date: 2013-03-12 Interventions: Drug: Tauroursodeoxycholic Acid and Doxycycline |
Recruiting |
Study Name: A Safety Study of GSK3039294 in Healthy Volunteers and Patients With Systemic Amyloidosis Condition: Amyloidosis Date: 2015-11-09 Interventions: Drug: GSK3039294 GSK3039294 will be provided as white, opaque capsules. A single capsule or multiple cap |
Completed |
Study Name: A Study to Evaluate the Safety of GSK2398852 When Co-administered With GSK2315698 in Patients With Systemic Amyloidosis Condition: Amyloidosis Date: 2013-01-24 Interventions:
|
Recruiting |
Study Name: Body Composition in Systemic Amyloidosis Condition: Amyloidosis Date: 2014-02-24 Interventions: Other: Dietary advice Standard dietary advice are provided to all patients at baseline and during the fo |
Not yet recruiting |
Study Name: Renal AL Amyloid Involvement and NEOD001 Condition: Amyloidosis Date: 2017-04-26 Interventions:
|
Recruiting |
Study Name: Imaging Cardiac Amyloidosis: A Pilot Study Using F-18 Florbetapir Positron Emission Tomography Condition: Cardiac Amyloidosis Date: 2012-09-04 Interventions: Drug: F-18 florbetapir PET Cardiac PET images will be obtained following injection of F-18 labeled Florb |
Completed |
Study Name: Bortezomib for Immunoglobulin Light Chain(AL) Amyloidosis Condition: Amyloidosis Date: 2015-06-24 Interventions: Drug: bortezominb and dexamethasone The initial BD regimen included bortezomib (1.3 mg/m2 i.v.) and dexa |